Home › Funds › Patient Square Capital LP › EYPT

Patient Square Capital LP position in EYPT

EYEPOINT INC · Industrials

Patient Square Capital LP reported holding 720,000 shares of EYPT (EYEPOINT INC) in its Q2 2026 13F filing — a position valued at US$10.3M, representing 1.59% of its reported portfolio and ranking #18 among its reported holdings. Patient Square Capital LP has disclosed EYPT holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)720.00K sh
Reported value held$10.30M
Portfolio Weight1.59%
First reportedQ3 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Patient Square Capital LP's EYPT position evolved

Patient Square Capital LP first disclosed a stake in EYPT in Q3 2024 at 1,361,979 shares (US$10.9M). The position peaked in Q3 2025 at 1,011,839 shares, worth US$14.4M. Across 8 filings, Patient Square Capital LP increased the stake 3 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 720,000 shares valued at US$10.3M — a reduction of -75,000 shares quarter over quarter.. Notable position changes include a 25% trim in Q3 2025 (shares rose 28% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 1.36M $10.88M New
Q4 2024 1.41M $10.51M Add
Q1 2025 1.48M $8.03M Add
Q2 2025 1.35M $12.73M Reduce
Q3 2025 1.01M $14.41M Reduce
Q4 2025 780.00K $14.25M Reduce
Q1 2026 795.00K $10.25M Add
Q2 2026 720.00K $10.30M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EYPT and 13F data

EYPT (EYEPOINT INC) is a Industrials company. 42 other funds we track also report a position in EYPT — the largest reported positions include MONTANOVA CAPITAL, LLC (US$118.6M), Cormorant Asset Management, LP (US$100.1M), Commodore Capital LP (US$65.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EYPT

All EYPT fund holders →

FAQ

How long has Patient Square Capital LP held EYPT?

Patient Square Capital LP has disclosed EYPT holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

What is Patient Square Capital LP's current position in EYPT?

As of Q2 2026, Patient Square Capital LP holds 720.00K shares of EYPT (EYEPOINT INC), valued at $10.30M, representing 1.59% of its reported portfolio and ranking #18.

Has Patient Square Capital LP been buying or selling EYPT?

In the latest 13F filing (Q2 2026), Patient Square Capital LP reduced its position in EYPT. The position peaked in Q3 2025 at 1.01M shares.

Which other funds hold EYPT?

Other major institutional holders of EYPT include MONTANOVA CAPITAL, LLC, Cormorant Asset Management, LP, Commodore Capital LP, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.